Pirfenidone Anti-Fibrotic Effects Are Partially Mediated by the Inhibition of MUC1 Bioactivation

Oncotarget - United States
doi 10.18632/oncotarget.27526
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Anti-Fibrotic Effects of Pirfenidone and Rapamycin in Primary IPF Fibroblasts and Human Alveolar Epithelial Cells

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

Anti-Kl-6/Muc1 Monoclonal Antibody Reverses Resistance to Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Cytotoxicity by Capping MUC1

Cancer Letters
Cancer ResearchOncology
2019English

The Anti-Fibrotic Agent Pirfenidone Synergizes With Cisplatin in Killing Tumor Cells and Cancer-Associated Fibroblasts

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Growth Inhibition of Astrocytoma Cells by Farnesyl Transferase Inhibitors Is Mediated by a Combination of Anti-Proliferative, Pro-Apoptotic and Anti-Angiogenic Effects

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Paving the TRAIL to Anti-Fibrotic Therapy

Hepatology
MedicineHepatology
2016English

Cordyceps Sinensis : Anti-Fibrotic and Inflammatory Effects of a Cultured Polysaccharide Extract

Bioactive Carbohydrates and Dietary Fibre
Organic ChemistryBiochemistryFood Science
2018English

Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts

PLoS ONE
Multidisciplinary
2009English

Clathrin-Mediated Endocytosis of MUC1 Is Modulated by Its Glycosylation State

Molecular Biology of the Cell
Cell BiologyMolecular Biology
2000English

Angiogenesis, Cardiomyocyte Proliferation and Anti-Fibrotic Effects Underlie Structural Preservation Post-Infarction by Intramyocardially-Injected Cardiospheres

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy